Catheter Precision, Inc. (VTAK)
- Previous Close
0.5500 - Open
0.5499 - Bid 0.5110 x 900
- Ask 0.5899 x 800
- Day's Range
0.5281 - 0.6000 - 52 Week Range
0.3400 - 1.3300 - Volume
34,787 - Avg. Volume
37,704 - Market Cap (intraday)
4.145M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-12.9900 - Earnings Date May 31, 2024 - Jun 4, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.10
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
www.catheterprecision.comRecent News: VTAK
Performance Overview: VTAK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VTAK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VTAK
Valuation Measures
Market Cap
4.14M
Enterprise Value
951.54k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.80
Price/Book (mrq)
0.20
Enterprise Value/Revenue
2.15
Enterprise Value/EBITDA
-0.06
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-45.15%
Return on Equity (ttm)
-463.48%
Revenue (ttm)
442k
Net Income Avi to Common (ttm)
-71.37M
Diluted EPS (ttm)
-12.9900
Balance Sheet and Cash Flow
Total Cash (mrq)
3.56M
Total Debt/Equity (mrq)
1.75%
Levered Free Cash Flow (ttm)
-12.52M